Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis
about
Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative NeoplasmsSetting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.Drug Repurposing to treat Asthma and Allergic Disorders: Progress and Prospects.Evaluation of vascular events in patients with myeloproliferative syndromes and mutations of either the januskinase-2 or calreticulin gene at the university hospital Krems from 2008 to 2015.Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.
P2860
Critical appraisal of the role of ruxolitinib in myeloproliferative neoplasm-associated myelofibrosis
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Critical appraisal of the role ...... plasm-associated myelofibrosis
@ast
Critical appraisal of the role ...... plasm-associated myelofibrosis
@en
Critical appraisal of the role ...... plasm-associated myelofibrosis
@nl
type
label
Critical appraisal of the role ...... plasm-associated myelofibrosis
@ast
Critical appraisal of the role ...... plasm-associated myelofibrosis
@en
Critical appraisal of the role ...... plasm-associated myelofibrosis
@nl
prefLabel
Critical appraisal of the role ...... plasm-associated myelofibrosis
@ast
Critical appraisal of the role ...... plasm-associated myelofibrosis
@en
Critical appraisal of the role ...... plasm-associated myelofibrosis
@nl
P2860
P356
P1476
Critical appraisal of the role ...... plasm-associated myelofibrosis
@en
P2093
Giovanni Barosi
Vittorio Rosti
P2860
P304
P356
10.2147/OTT.S31916
P407
P577
2015-01-01T00:00:00Z